Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #96482 on Biotech Values
poorgradstudent
05/27/10 4:16 PM
#96483 RE: genisi #96482
DewDiligence
05/27/10 5:39 PM
#96488 RE: genisi #96482
Barr is somewhat different from other generic-drug companies—their self-proclaimed raison d’etre is to pursue challenges in cases that other companies won’t touch. CEO Bruce Downey singled out drugs with a risk-management program as one facet of the business strategy.